EVERGRAF 0.25MG
Evergraf 0.25mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor).Evergraf 0.25mg is an immunosuppressive macrolide.
USED FOR
Breast cancerPatient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Rapact. Evergraf 0.25mg is used in an advanced stage of breast cancer.
Neuroendocrine tumors
Evergraf 0.25mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer.
Renal cell cancer
Patient treating with Evergraf 0.25mg after the failure of treatment with Sunitinib or Sorafenib.
Evergraf 0.25mg also used in the condition of;
Heart, liver, kidney transplantation
Waldenström macroglobulinemia
Other carcinoid tumors.
MECHANISM OF ACTION
Evergraf is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase.Evergraf bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR complex 1 (mTORC1) this leads to inhibition of mTOR kinase activity.
Evergraf decreased the effect of S6 ribosomal protein kinase (S6K1) and eukaryotic elongation factor 4E binding protein (4E-BP1) which are essential for protein synthesis.
mTOR inhibited by Evergraf lead to reduce cell multiplication and angiogenesis.
DOSAGE AND ADMINISTRATION
The recommended dose of the Tablet Evergraf is 10mg should be taken as a single dose in all carcinogenic condition, except organ transplantation.Organ transplant: 0.75mg orally twice daily.
Brain/intracranial tumor: 4.5mg/m2 orally once a day (for both pediatric and adult dose)
Hepatic impairment: dose reduced to 7.5mg once daily followed by 5mg as a single dose.
Evergrafis in tablet form. It should be administered orally at the same time every day.
Evergrafshould is taken with or without food.
Evergraftablets should not crush or broken.
SIDE EFFECTS
The side effects of Evergraf 0.25mg tablets are predicted by the terms of their onset, duration, and severitySide effects of Evergraf 0.25mg are preventable and it is minimized :
Mouth sores, Mucositis, Stomatitis or esophagitis, Infection, Rash, itching or dry skin, Fatigue, Diarrhea, Edema, Stomach pain, Nausea, vomiting, Fever, Weakness or asthenia, Headache.
STORAGE
Evergraf 0.25mg should be stored in room temperatureKeep away from moisture, heat, and light
MISSED DOSE
In the case of the missed dose, patients must consult with the medical practitioner and follow the instructions given by them.On the other hand, the missed dose should be avoiding and follow the regular dosing schedule.
Comments
Post a Comment